4319 related articles for article (PubMed ID: 3106043)
1. Improved tumor localization of 111In labeled monoclonal antibody with chelator administration to host nude mice.
Lockshin A; Stehlin JS
Eur J Nucl Med; 1987; 12(11):573-5. PubMed ID: 3106043
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines. Part 2.
Hallin PA; Adams VR
J Am Pharm Assoc (Wash); 1997; NS37(6):706-9. PubMed ID: 9425801
[TBL] [Abstract][Full Text] [Related]
3. Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs.
Heaton KM; Ju G; Grimm EA
Ann Surg Oncol; 1994 May; 1(3):198-203. PubMed ID: 7842289
[TBL] [Abstract][Full Text] [Related]
4. RNA-tumorviruses, oncogenes, and their possible role in human carcinogenesis.
Hehlmann R; Schetters H; Kreeb G; Erfle V; Schmidt J; Luz A
Klin Wochenschr; 1983 Dec; 61(24):1217-31. PubMed ID: 6319800
[TBL] [Abstract][Full Text] [Related]
5. Modifications of the metastasizing process through polypassage of tumoral fragments.
Dumitrescu S
Arch Immunol Ther Exp (Warsz); 1967; 15(5):801-5. PubMed ID: 5595082
[No Abstract] [Full Text] [Related]
6. Melanocytic dysplasia and melanoma.
Cook MG; Robertson I
Histopathology; 1985 Jun; 9(6):647-58. PubMed ID: 4029904
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the larynx--a distant metastasis from a rectal primary.
Hilger AW; Prichard AJ; Jones T
J Laryngol Otol; 1998 Feb; 112(2):199-201. PubMed ID: 9578888
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells.
Komatsu Y; Hayashi H
J Antibiot (Tokyo); 1998 Jan; 51(1):89-91. PubMed ID: 9531994
[No Abstract] [Full Text] [Related]
9. Melanoma in children and adolescents.
Wu SJ; Lambert DR
Pediatr Dermatol; 1997; 14(2):87-92. PubMed ID: 9144691
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node metastasis in experimental melanoma: relationships among primary tumor size, lymphatic vessel diameter and 99mTc-labeled human serum albumin clearance.
Nathanson SD; Anaya P; Avery M; Hetzel FW; Sarantou T; Havstad S
Ann Surg Oncol; 1997 Mar; 4(2):161-8. PubMed ID: 9084854
[TBL] [Abstract][Full Text] [Related]
11. Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
Maelandsmo GM; Holm R; Fodstad O; Kerbel RS; Flørenes VA
Am J Pathol; 1996 Dec; 149(6):1813-22. PubMed ID: 8952518
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Hicklin DJ; Kageshita T; Ferrone S
Tissue Antigens; 1996 Jul; 48(1):38-46. PubMed ID: 8864173
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids.
Rofstad EK; Eide K; Skøyum R; Hystad ME; Lyng H
Int J Radiat Biol; 1996 Sep; 70(3):241-9. PubMed ID: 8800195
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of antitumor efficacy by the combination of actinomycin D with tumor necrosis factor-alpha and interferon-gamma on a melanoma model in mice.
Lasek W; Wańkowicz A; Kuc K; Feleszko W; Giermasz A; Jakóbisiak M
Oncology; 1996; 53(1):31-7. PubMed ID: 8570128
[TBL] [Abstract][Full Text] [Related]
16. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma.
Gamel JW; McLean IW; McCurdy JB
Cancer; 1993 Apr; 71(7):2299-305. PubMed ID: 8453550
[TBL] [Abstract][Full Text] [Related]
17. Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes.
Filgueira L; Zuber M; Merlo A; Harder F; Heberer M; Spagnoli GC
Eur J Cancer; 1993; 29A(12):1754-60. PubMed ID: 8398305
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
19. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.
Wilson BS; Imai K; Natali PG; Ferrone S
Int J Cancer; 1981 Sep; 28(3):293-300. PubMed ID: 7033148
[TBL] [Abstract][Full Text] [Related]
20. p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.
Dippold WG; Jay G; DeLeo AB; Khoury G; Old LJ
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1695-9. PubMed ID: 6940183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
